

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 4.96158501 |
| 2 | cullin deneddylation (GO:0010388) | 4.37162182 |
| 3 | protein deneddylation (GO:0000338) | 4.05025999 |
| 4 | branched-chain amino acid catabolic process (GO:0009083) | 3.97999321 |
| 5 | L-serine metabolic process (GO:0006563) | 3.68718963 |
| 6 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.58487601 |
| 7 | lactate metabolic process (GO:0006089) | 3.45793906 |
| 8 | protein neddylation (GO:0045116) | 3.43220352 |
| 9 | aldehyde catabolic process (GO:0046185) | 3.40181691 |
| 10 | respiratory chain complex IV assembly (GO:0008535) | 3.39397881 |
| 11 | DNA double-strand break processing (GO:0000729) | 3.36462240 |
| 12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32105555 |
| 13 | peptidyl-cysteine modification (GO:0018198) | 3.30803152 |
| 14 | ubiquinone biosynthetic process (GO:0006744) | 3.30739594 |
| 15 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.25917837 |
| 16 | sterol biosynthetic process (GO:0016126) | 3.24775810 |
| 17 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24712492 |
| 18 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24712492 |
| 19 | platelet dense granule organization (GO:0060155) | 3.24315664 |
| 20 | ubiquinone metabolic process (GO:0006743) | 3.23021937 |
| 21 | positive regulation of mitochondrial fission (GO:0090141) | 3.22864302 |
| 22 | cholesterol biosynthetic process (GO:0006695) | 3.21709769 |
| 23 | anterograde synaptic vesicle transport (GO:0048490) | 3.13782656 |
| 24 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.12775752 |
| 25 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.07548245 |
| 26 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.07107518 |
| 27 | negative regulation of ligase activity (GO:0051352) | 3.07107518 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.02183881 |
| 29 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01991625 |
| 30 | protein complex biogenesis (GO:0070271) | 3.01449598 |
| 31 | tricarboxylic acid cycle (GO:0006099) | 2.96595383 |
| 32 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.94747147 |
| 33 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.94747147 |
| 34 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.94747147 |
| 35 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.93496886 |
| 36 | DNA damage response, detection of DNA damage (GO:0042769) | 2.92288294 |
| 37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.91973419 |
| 38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.91973419 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 2.88249197 |
| 40 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83644324 |
| 41 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.82014251 |
| 42 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.82014251 |
| 43 | quinone metabolic process (GO:1901661) | 2.81764032 |
| 44 | branched-chain amino acid metabolic process (GO:0009081) | 2.81614674 |
| 45 | lysine catabolic process (GO:0006554) | 2.80250159 |
| 46 | lysine metabolic process (GO:0006553) | 2.80250159 |
| 47 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78695032 |
| 48 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.78533493 |
| 49 | quinone biosynthetic process (GO:1901663) | 2.78394197 |
| 50 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.77686169 |
| 51 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.77686169 |
| 52 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.75883783 |
| 53 | C-terminal protein lipidation (GO:0006501) | 2.74444586 |
| 54 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74075674 |
| 55 | peptidyl-histidine modification (GO:0018202) | 2.73524611 |
| 56 | daunorubicin metabolic process (GO:0044597) | 2.73427060 |
| 57 | polyketide metabolic process (GO:0030638) | 2.73427060 |
| 58 | doxorubicin metabolic process (GO:0044598) | 2.73427060 |
| 59 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.71842467 |
| 60 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.71842467 |
| 61 | nucleobase catabolic process (GO:0046113) | 2.71790006 |
| 62 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.70541489 |
| 63 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69096989 |
| 64 | DNA ligation (GO:0006266) | 2.65403491 |
| 65 | establishment of viral latency (GO:0019043) | 2.65117353 |
| 66 | tRNA aminoacylation for protein translation (GO:0006418) | 2.64099967 |
| 67 | C-terminal protein amino acid modification (GO:0018410) | 2.62637102 |
| 68 | amino acid activation (GO:0043038) | 2.62573497 |
| 69 | tRNA aminoacylation (GO:0043039) | 2.62573497 |
| 70 | purine nucleobase biosynthetic process (GO:0009113) | 2.61176359 |
| 71 | lipid particle organization (GO:0034389) | 2.60102259 |
| 72 | glyoxylate metabolic process (GO:0046487) | 2.59802687 |
| 73 | iron-sulfur cluster assembly (GO:0016226) | 2.59068246 |
| 74 | metallo-sulfur cluster assembly (GO:0031163) | 2.59068246 |
| 75 | regulation of cellular amine metabolic process (GO:0033238) | 2.58461779 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 2.58190824 |
| 77 | positive regulation of ligase activity (GO:0051351) | 2.56456173 |
| 78 | positive regulation of actin filament depolymerization (GO:0030836) | 2.54390548 |
| 79 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.52783487 |
| 80 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.52395403 |
| 81 | NADH dehydrogenase complex assembly (GO:0010257) | 2.52395403 |
| 82 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.52395403 |
| 83 | establishment of integrated proviral latency (GO:0075713) | 2.51954268 |
| 84 | isoprenoid biosynthetic process (GO:0008299) | 2.50048913 |
| 85 | L-methionine salvage (GO:0071267) | 2.49525575 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 2.49525575 |
| 87 | amino acid salvage (GO:0043102) | 2.49525575 |
| 88 | glutathione derivative biosynthetic process (GO:1901687) | 2.48860855 |
| 89 | glutathione derivative metabolic process (GO:1901685) | 2.48860855 |
| 90 | regulation of cilium movement (GO:0003352) | 2.47056309 |
| 91 | IMP biosynthetic process (GO:0006188) | 2.46557132 |
| 92 | mannosylation (GO:0097502) | 2.45777522 |
| 93 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.43235268 |
| 94 | regulation of ligase activity (GO:0051340) | 2.42795200 |
| 95 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.41342420 |
| 96 | protein polyglutamylation (GO:0018095) | 2.41233990 |
| 97 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.41164254 |
| 98 | histone H2A acetylation (GO:0043968) | 2.40677097 |
| 99 | pseudouridine synthesis (GO:0001522) | 2.39135219 |
| 100 | kynurenine metabolic process (GO:0070189) | 2.38918560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.92487494 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.34679705 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.91368928 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.44926865 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05545260 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.04285128 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.91997264 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.61869592 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58792655 |
| 10 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.52490219 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.41401455 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.38394979 |
| 13 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.28405693 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.26675927 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.06288271 |
| 16 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00713520 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96376437 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94465656 |
| 19 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.81562674 |
| 20 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81479573 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79585494 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78969662 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76898515 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76182177 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74198449 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68470402 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61250243 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61001175 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60765104 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58307687 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56738205 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53341761 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49861454 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49277634 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48918777 |
| 36 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.46204144 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45960952 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45029284 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41518802 |
| 40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39913194 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39086285 |
| 42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38541245 |
| 43 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37872301 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.36764199 |
| 45 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36598451 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33381071 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31703559 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31238369 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27370612 |
| 50 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27242641 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.22451356 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21095224 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19872104 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14166437 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13667006 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13384721 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10556705 |
| 58 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06097258 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05602440 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05483245 |
| 61 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.05381002 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04972799 |
| 63 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.00652294 |
| 64 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99676078 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99634501 |
| 66 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99461585 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99163322 |
| 68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99163322 |
| 69 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99091026 |
| 70 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97708363 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97333876 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96557950 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95376519 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94856310 |
| 75 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94310444 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94000925 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93615814 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93339385 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93271388 |
| 80 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93269472 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93073582 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92922459 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92860771 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.92493589 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92374922 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91820770 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90590815 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90060522 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87989411 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87989411 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87796324 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87737669 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87341135 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86410924 |
| 95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86183486 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85947733 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85405093 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84154800 |
| 99 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83663065 |
| 100 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83663065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 2.99054380 |
| 2 | MP0001529_abnormal_vocalization | 2.73639692 |
| 3 | MP0003122_maternal_imprinting | 2.72926251 |
| 4 | MP0003941_abnormal_skin_development | 2.56446544 |
| 5 | MP0008058_abnormal_DNA_repair | 2.37553611 |
| 6 | MP0003186_abnormal_redox_activity | 2.27292658 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.20850296 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.17733187 |
| 9 | MP0002254_reproductive_system_inflammat | 2.14230471 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.10668343 |
| 11 | MP0003195_calcinosis | 2.09037518 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.04873127 |
| 13 | MP0003011_delayed_dark_adaptation | 2.04197047 |
| 14 | MP0003693_abnormal_embryo_hatching | 1.99543263 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 1.96837898 |
| 16 | MP0001984_abnormal_olfaction | 1.89618119 |
| 17 | MP0004147_increased_porphyrin_level | 1.85867991 |
| 18 | MP0003718_maternal_effect | 1.85293715 |
| 19 | MP0005332_abnormal_amino_acid | 1.84249729 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.80601203 |
| 21 | MP0008789_abnormal_olfactory_epithelium | 1.79140255 |
| 22 | MP0005365_abnormal_bile_salt | 1.71724806 |
| 23 | MP0005367_renal/urinary_system_phenotyp | 1.71514638 |
| 24 | MP0000516_abnormal_urinary_system | 1.71514638 |
| 25 | MP0002736_abnormal_nociception_after | 1.67662419 |
| 26 | MP0004270_analgesia | 1.64508132 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.60783698 |
| 28 | MP0003121_genomic_imprinting | 1.59881008 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.59162860 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.56857564 |
| 31 | MP0006054_spinal_hemorrhage | 1.55284913 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.54326850 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.52675362 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.50938392 |
| 35 | MP0010094_abnormal_chromosome_stability | 1.49690992 |
| 36 | MP0009840_abnormal_foam_cell | 1.49156791 |
| 37 | MP0002090_abnormal_vision | 1.46413947 |
| 38 | MP0003880_abnormal_central_pattern | 1.43653312 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41422679 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.39376940 |
| 41 | MP0001764_abnormal_homeostasis | 1.36425609 |
| 42 | MP0005253_abnormal_eye_physiology | 1.35301487 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.28024524 |
| 44 | MP0005499_abnormal_olfactory_system | 1.28024524 |
| 45 | MP0002938_white_spotting | 1.26337566 |
| 46 | MP0000749_muscle_degeneration | 1.26136978 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.24732570 |
| 48 | MP0002233_abnormal_nose_morphology | 1.21660208 |
| 49 | MP0004133_heterotaxia | 1.21207829 |
| 50 | MP0009697_abnormal_copulation | 1.20065207 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.19860367 |
| 52 | MP0005379_endocrine/exocrine_gland_phen | 1.19537742 |
| 53 | MP0003137_abnormal_impulse_conducting | 1.13387765 |
| 54 | MP0003646_muscle_fatigue | 1.09318933 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.09004746 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.08626908 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.07870318 |
| 58 | MP0000358_abnormal_cell_content/ | 1.07194364 |
| 59 | MP0000647_abnormal_sebaceous_gland | 1.06845187 |
| 60 | MP0001666_abnormal_nutrient_absorption | 1.04521578 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.03383676 |
| 62 | MP0009046_muscle_twitch | 1.03372876 |
| 63 | MP0002653_abnormal_ependyma_morphology | 1.01744830 |
| 64 | MP0001756_abnormal_urination | 1.00805532 |
| 65 | MP0004215_abnormal_myocardial_fiber | 0.99752375 |
| 66 | MP0003787_abnormal_imprinting | 0.98007201 |
| 67 | MP0004142_abnormal_muscle_tone | 0.96870877 |
| 68 | MP0000751_myopathy | 0.95715919 |
| 69 | MP0001542_abnormal_bone_strength | 0.94200312 |
| 70 | MP0002751_abnormal_autonomic_nervous | 0.94079394 |
| 71 | MP0003950_abnormal_plasma_membrane | 0.91238956 |
| 72 | MP0004233_abnormal_muscle_weight | 0.89356946 |
| 73 | MP0001188_hyperpigmentation | 0.88709561 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.88516517 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.86920386 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82611455 |
| 77 | MP0001968_abnormal_touch/_nociception | 0.82458852 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.81874227 |
| 79 | MP0003111_abnormal_nucleus_morphology | 0.80640884 |
| 80 | MP0005410_abnormal_fertilization | 0.78723853 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.78557300 |
| 82 | MP0005360_urolithiasis | 0.77659554 |
| 83 | MP0003123_paternal_imprinting | 0.77657241 |
| 84 | MP0002163_abnormal_gland_morphology | 0.77406871 |
| 85 | MP0001299_abnormal_eye_distance/ | 0.77362477 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.75973146 |
| 87 | MP0001486_abnormal_startle_reflex | 0.75777964 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74170369 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.73693888 |
| 90 | MP0002269_muscular_atrophy | 0.73374567 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.72981359 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.72873815 |
| 93 | MP0001293_anophthalmia | 0.72611052 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.72580802 |
| 95 | MP0002229_neurodegeneration | 0.71192424 |
| 96 | MP0003786_premature_aging | 0.71184852 |
| 97 | MP0008872_abnormal_physiological_respon | 0.69888306 |
| 98 | MP0000049_abnormal_middle_ear | 0.69851198 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.68169971 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 0.67907777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute encephalopathy (HP:0006846) | 3.97524507 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.95138160 |
| 3 | Abnormality of glycolysis (HP:0004366) | 3.78272182 |
| 4 | Increased serum pyruvate (HP:0003542) | 3.71485193 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65921067 |
| 6 | Hyperglycinemia (HP:0002154) | 3.38648237 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.26432231 |
| 8 | Ependymoma (HP:0002888) | 3.14991752 |
| 9 | Increased CSF lactate (HP:0002490) | 3.09077166 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.08877138 |
| 11 | Cerebral edema (HP:0002181) | 3.08735848 |
| 12 | Abnormality of the labia minora (HP:0012880) | 2.92437143 |
| 13 | Hepatic necrosis (HP:0002605) | 2.87675233 |
| 14 | Hepatocellular necrosis (HP:0001404) | 2.87279975 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 2.80453881 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80453881 |
| 17 | Abnormality of serum amino acid levels (HP:0003112) | 2.78322321 |
| 18 | Intestinal atresia (HP:0011100) | 2.69386063 |
| 19 | Poor suck (HP:0002033) | 2.64804280 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59294058 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59294058 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.55181107 |
| 23 | Lactic acidosis (HP:0003128) | 2.52299569 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 2.47480628 |
| 25 | Methylmalonic acidemia (HP:0002912) | 2.42581683 |
| 26 | Methylmalonic aciduria (HP:0012120) | 2.41055045 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 2.38035958 |
| 28 | Lethargy (HP:0001254) | 2.37213897 |
| 29 | Astrocytoma (HP:0009592) | 2.36612402 |
| 30 | Abnormality of the astrocytes (HP:0100707) | 2.36612402 |
| 31 | Hyperglycinuria (HP:0003108) | 2.36175077 |
| 32 | Neoplasm of the adrenal gland (HP:0100631) | 2.34724861 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.31363082 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.31363082 |
| 35 | Hyperalaninemia (HP:0003348) | 2.31363082 |
| 36 | Type I transferrin isoform profile (HP:0003642) | 2.27172718 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24022836 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.23720418 |
| 39 | Increased serum lactate (HP:0002151) | 2.23264840 |
| 40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22292839 |
| 41 | Respiratory failure (HP:0002878) | 2.20300204 |
| 42 | Cortical dysplasia (HP:0002539) | 2.19563671 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.18984329 |
| 44 | Hypothermia (HP:0002045) | 2.14447969 |
| 45 | True hermaphroditism (HP:0010459) | 2.14369073 |
| 46 | Disproportionate short-trunk short stature (HP:0003521) | 2.13657379 |
| 47 | Delayed gross motor development (HP:0002194) | 2.13394405 |
| 48 | Polyphagia (HP:0002591) | 2.11895725 |
| 49 | Abnormal protein glycosylation (HP:0012346) | 2.10735959 |
| 50 | Abnormal glycosylation (HP:0012345) | 2.10735959 |
| 51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10735959 |
| 52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10735959 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08616028 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.07891822 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.07891822 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.05557497 |
| 57 | Glioma (HP:0009733) | 2.05293049 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04663609 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.04041970 |
| 60 | Congenital primary aphakia (HP:0007707) | 2.03688996 |
| 61 | Progressive inability to walk (HP:0002505) | 2.03106042 |
| 62 | CNS demyelination (HP:0007305) | 2.01984975 |
| 63 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01695403 |
| 64 | Bifid tongue (HP:0010297) | 2.01463392 |
| 65 | Exercise intolerance (HP:0003546) | 2.00505228 |
| 66 | Type 2 muscle fiber atrophy (HP:0003554) | 1.99591107 |
| 67 | Pancreatic cysts (HP:0001737) | 1.99187103 |
| 68 | Gait imbalance (HP:0002141) | 1.98800437 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 1.96944047 |
| 70 | Cholecystitis (HP:0001082) | 1.96944047 |
| 71 | Failure to thrive in infancy (HP:0001531) | 1.96104940 |
| 72 | Optic disc pallor (HP:0000543) | 1.96039670 |
| 73 | Agnosia (HP:0010524) | 1.95919359 |
| 74 | Colon cancer (HP:0003003) | 1.86258293 |
| 75 | Opisthotonus (HP:0002179) | 1.85883149 |
| 76 | Postnatal microcephaly (HP:0005484) | 1.85002525 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 1.83947443 |
| 78 | Bile duct proliferation (HP:0001408) | 1.83947443 |
| 79 | Hypokinesia (HP:0002375) | 1.83639651 |
| 80 | Degeneration of anterior horn cells (HP:0002398) | 1.79380050 |
| 81 | Abnormality of the anterior horn cell (HP:0006802) | 1.79380050 |
| 82 | Generalized aminoaciduria (HP:0002909) | 1.79357608 |
| 83 | Muscular hypotonia of the trunk (HP:0008936) | 1.79158167 |
| 84 | Cerebral hypomyelination (HP:0006808) | 1.78491990 |
| 85 | Double outlet right ventricle (HP:0001719) | 1.77917740 |
| 86 | Congenital malformation of the right heart (HP:0011723) | 1.77917740 |
| 87 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77132062 |
| 88 | Leukodystrophy (HP:0002415) | 1.77014886 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76598159 |
| 90 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.75910087 |
| 91 | Nephronophthisis (HP:0000090) | 1.74883040 |
| 92 | Hyperammonemia (HP:0001987) | 1.73534777 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72164768 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.72164768 |
| 95 | Rhabdomyosarcoma (HP:0002859) | 1.71764253 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71617403 |
| 97 | Sclerocornea (HP:0000647) | 1.71092587 |
| 98 | Decreased muscle mass (HP:0003199) | 1.69581069 |
| 99 | Lissencephaly (HP:0001339) | 1.68827151 |
| 100 | Abnormality of vitamin B metabolism (HP:0004340) | 1.68346843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.94502220 |
| 2 | NEK1 | 2.76607681 |
| 3 | MAP3K12 | 2.60884979 |
| 4 | MAP4K2 | 2.58769231 |
| 5 | SRPK1 | 2.50525048 |
| 6 | BCR | 2.49536848 |
| 7 | WNK3 | 2.48537759 |
| 8 | BCKDK | 2.38663968 |
| 9 | STK16 | 2.34991933 |
| 10 | PDK2 | 2.13817897 |
| 11 | MST4 | 2.06819872 |
| 12 | LIMK1 | 2.05537708 |
| 13 | BUB1 | 2.04522486 |
| 14 | TSSK6 | 1.90858476 |
| 15 | MUSK | 1.89527234 |
| 16 | EIF2AK3 | 1.86566874 |
| 17 | PLK3 | 1.77671876 |
| 18 | MAP3K4 | 1.77539175 |
| 19 | CSNK1G3 | 1.70524111 |
| 20 | ERBB3 | 1.70190762 |
| 21 | CSNK1G1 | 1.68779139 |
| 22 | FRK | 1.68349119 |
| 23 | VRK2 | 1.61982497 |
| 24 | PBK | 1.57805289 |
| 25 | CSNK1G2 | 1.55936081 |
| 26 | GRK1 | 1.55020616 |
| 27 | STK38L | 1.52512917 |
| 28 | PIM2 | 1.46897432 |
| 29 | PLK2 | 1.46330573 |
| 30 | SIK3 | 1.44754856 |
| 31 | ZAK | 1.42502106 |
| 32 | EIF2AK1 | 1.40627089 |
| 33 | NUAK1 | 1.38163590 |
| 34 | TNIK | 1.35609810 |
| 35 | CSNK1A1L | 1.33761512 |
| 36 | MKNK1 | 1.29811966 |
| 37 | PLK4 | 1.29538094 |
| 38 | ADRBK2 | 1.26898383 |
| 39 | ACVR1B | 1.25071448 |
| 40 | PINK1 | 1.24677404 |
| 41 | MAP2K7 | 1.22896124 |
| 42 | DYRK2 | 1.21497827 |
| 43 | BMPR1B | 1.14717978 |
| 44 | TESK1 | 1.12183809 |
| 45 | PLK1 | 1.07421982 |
| 46 | BRSK2 | 1.07113551 |
| 47 | MKNK2 | 1.06839938 |
| 48 | FER | 1.06191146 |
| 49 | CASK | 1.05525316 |
| 50 | STK24 | 1.02336899 |
| 51 | TTK | 1.00617922 |
| 52 | MINK1 | 0.94343516 |
| 53 | PAK4 | 0.93765231 |
| 54 | MYLK | 0.89799547 |
| 55 | PAK3 | 0.86640477 |
| 56 | PHKG2 | 0.85615189 |
| 57 | PHKG1 | 0.85615189 |
| 58 | PRKCE | 0.84376814 |
| 59 | VRK1 | 0.84104554 |
| 60 | OBSCN | 0.81248266 |
| 61 | BRSK1 | 0.78162109 |
| 62 | MAPK13 | 0.73620071 |
| 63 | PRKD3 | 0.68509304 |
| 64 | EPHA2 | 0.68353096 |
| 65 | PRKCI | 0.66916755 |
| 66 | OXSR1 | 0.65497755 |
| 67 | DAPK1 | 0.62708491 |
| 68 | PRKCG | 0.62413102 |
| 69 | STK39 | 0.58523058 |
| 70 | MAP3K5 | 0.58218671 |
| 71 | WEE1 | 0.58146927 |
| 72 | MARK1 | 0.56895166 |
| 73 | ERBB4 | 0.55405539 |
| 74 | CAMK2D | 0.54724750 |
| 75 | CCNB1 | 0.54670362 |
| 76 | NME1 | 0.53092124 |
| 77 | PAK6 | 0.49905976 |
| 78 | CDK19 | 0.46656740 |
| 79 | STK3 | 0.46078031 |
| 80 | ARAF | 0.44320600 |
| 81 | INSRR | 0.43079534 |
| 82 | GRK7 | 0.42449833 |
| 83 | DYRK1B | 0.42431869 |
| 84 | ABL2 | 0.42383869 |
| 85 | CSNK1A1 | 0.42061044 |
| 86 | TAF1 | 0.41331095 |
| 87 | EPHA3 | 0.39252415 |
| 88 | CAMK2A | 0.38531859 |
| 89 | CDK14 | 0.38169879 |
| 90 | FLT3 | 0.37761301 |
| 91 | CSNK2A1 | 0.36530870 |
| 92 | MAP3K3 | 0.35611497 |
| 93 | AURKB | 0.35033378 |
| 94 | CAMK2G | 0.34701963 |
| 95 | EIF2AK2 | 0.34249335 |
| 96 | NME2 | 0.34068933 |
| 97 | ATM | 0.32209552 |
| 98 | ILK | 0.31231893 |
| 99 | LMTK2 | 0.28576278 |
| 100 | CDK18 | 0.28490888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.37077020 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.59238068 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45111177 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32995192 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.27644807 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.27445583 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.24219652 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.22982929 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.20978473 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20473725 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07935361 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.06750091 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97817578 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97684803 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80037141 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79799998 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77103420 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74197188 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.73861600 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.73046584 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.71899149 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69570527 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.66891886 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66722543 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62966942 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57434756 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46694087 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46093062 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.44426735 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42447563 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.36129980 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35886952 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33069648 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29131940 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26575469 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25979883 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.21741648 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21386969 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20852207 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14763314 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14073223 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12978305 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12668271 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11423754 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09091861 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08028780 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07336517 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04440371 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02590257 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01618915 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 0.99720849 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99650947 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98508604 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95783985 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.94830844 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94251307 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93375707 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93230303 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92982320 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.88118602 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.87836890 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87747464 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87187906 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86014108 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.83322932 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79458994 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78044617 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77513748 |
| 69 | RNA transport_Homo sapiens_hsa03013 | 0.76983771 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76462550 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.74423610 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73648513 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73647564 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73160529 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71596394 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67960166 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65244165 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61224166 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58295140 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57647138 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57611674 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56474701 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.56455643 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56252874 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54274243 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54085924 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51355238 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50056519 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48937059 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48913544 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48755857 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.47148940 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41265685 |
| 94 | Spliceosome_Homo sapiens_hsa03040 | 0.39463371 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38263715 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37881510 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37701565 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35537607 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34800158 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33392814 |

